References: Astrup, A., Carraro, R., Finer, N., Harper, A., et al
A report from the EMAs PRAC, published on 12 April 2024, said: After reviewing the available evidence from non-clinical studies, clinical trials, post-marketing surveillance data and the available studies the PRAC considers that no update to the product information is warranted. The PRAC statement said that market authorisation holders would continue to monitor events, including new studies, as part of their pharmacovigilance activities
Stay skeptical, stay curious, and keep validating CJC 1295 Ipamorelin claims against primary sources as formulations and regulations evolve
You dont need to do this math yourself
Studies show that 70% of individuals who undergo significant weight loss seek skin tightening solutions (Skin & Shape)